Clinical Trial Update: Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy [Phase 2]

View source ↗

Summary

The update presents Phase 2 efficacy and safety results for MT-3995 in patients with Diabetic Nephropathy. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• MT-3995

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED